Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jian-jun Zou

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|October 9, 2008
Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover studyJian-Jun Zou, Hong-Jian Ji, Ding-Wei Wu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 23, 2009
A simple and sensitive HPLC-ESI-MS/MS method for the determination of andrographolide in human plasmaLi Xu, Da-wei Xiao, Sheng Lou, et al.
Die Pharmazie|May 23, 2015
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patientsJie Yang, Jun-Shan Zhou, Yan-Xia Zhao, et al.
Clinical Therapeutics|July 19, 2018
Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese SubjectsBai-Li Song, Meng Wan, Dan Tang, et al.
Die Pharmazie|September 6, 2008
Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteersJian-Jun Zou, Hong-Jian Ji, Xiao-Hua Zhou, et al.
Die Pharmazie|May 20, 2015
Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary interventionXue-Qing Liu, Song Lin, Lin-Lin Qiu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 2, 2008
Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography-positive/negative electrospray ionization tandem mass spectrometryJian-Jun Zou, Li Dai, Li Ding, et al.
Drug Design, Development and Therapy|March 23, 2026
Machine Learning Models Reveal New Risk Factors for Sub-/Supra-Therapeutic Concentrations of Sirolimus in Children with Vascular AnomaliesYa-Hui Hu, Wan-Xia Li, Lin Fan, et al.
European Journal of Clinical Pharmacology|September 25, 2012
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary interventionJian-Jun Zou, Hong-Guang Xie, Shao-Liang Chen, et al.
Plos One|January 14, 2014
Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitorJian-Jun Zou, Shao-Liang Chen, Jie Tan, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|October 9, 2008
Bioequivalence and pharmacokinetic comparison of a single 200-mg dose of meclofenoxate hydrochloride capsule and tablet formulations in healthy Chinese adult male volunteers: a randomized sequence, open-label, two-period crossover studyJian-Jun Zou, Hong-Jian Ji, Ding-Wei Wu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 23, 2009
A simple and sensitive HPLC-ESI-MS/MS method for the determination of andrographolide in human plasmaLi Xu, Da-wei Xiao, Sheng Lou, et al.
Die Pharmazie|May 23, 2015
ABCB1 hypomethylation is associated with decreased antiplatelet effects of clopidogrel in Chinese ischemic stroke patientsJie Yang, Jun-Shan Zhou, Yan-Xia Zhao, et al.
Clinical Therapeutics|July 19, 2018
Effects of CYP2C19 Genetic Polymorphisms on the Pharmacokinetic and Pharmacodynamic Properties of Clopidogrel and Its Active Metabolite in Healthy Chinese SubjectsBai-Li Song, Meng Wan, Dan Tang, et al.
Die Pharmazie|September 6, 2008
Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteersJian-Jun Zou, Hong-Jian Ji, Xiao-Hua Zhou, et al.
Die Pharmazie|May 20, 2015
Association of the use of amlodipine with clopidogrel response in Chinese patients undergoing percutaneous coronary interventionXue-Qing Liu, Song Lin, Lin-Lin Qiu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 2, 2008
Determination of betamethasone and betamethasone 17-monopropionate in human plasma by liquid chromatography-positive/negative electrospray ionization tandem mass spectrometryJian-Jun Zou, Li Dai, Li Ding, et al.
Drug Design, Development and Therapy|March 23, 2026
Machine Learning Models Reveal New Risk Factors for Sub-/Supra-Therapeutic Concentrations of Sirolimus in Children with Vascular AnomaliesYa-Hui Hu, Wan-Xia Li, Lin Fan, et al.
European Journal of Clinical Pharmacology|September 25, 2012
Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary interventionJian-Jun Zou, Hong-Guang Xie, Shao-Liang Chen, et al.
Plos One|January 14, 2014
Increased risk for developing major adverse cardiovascular events in stented Chinese patients treated with dual antiplatelet therapy after concomitant use of the proton pump inhibitorJian-Jun Zou, Shao-Liang Chen, Jie Tan, et al.
Pageof 5